Reaction
Fungal Foot Infection reporting signals
As of the last recalculation, Fungal Foot Infection appears in 421 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is TERBINAFINE HYDROCHLORIDE (PRR 45.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Terbinafine Hydrochloride | 8 | 45.4 | 45.4 |
| Bimekizumab | 13 | 31.1 | 31.1 |
| Ocrelizumab | 21 | 17.6 | 17.6 |
| Tafamidis | 4 | 16.9 | 16.9 |
| Risankizumab-Rzaa | 25 | 16.0 | 16.0 |